Peptide Synthesis by Molecular Hiving
The 3rd wave is large and green: Bachem’s scale-up of tag-assisted liquid-phase peptide manufacturing to meet the rising market demand.
Webinar CMC Process Development and Risk Mitigation
Developing peptide and oligonucleotide APIs demands a precise balance of efficiency, quality and compliance. To meet the growing demand for high-quality APIs for both clinical and commercial purposes, Bachem has established a comprehensive CMC development concept....
A second-generation process for the manufacturing of Liraglutide
In the growing peptide generics market, continued intensification and optimization of manufacturing processes are required for CDMOs to remain competitive on cost, speed, quality of peptide API while satisfying increasing regulatory requirements and sustainability...
Expert Round – Upscaling TIDES Manufacturing 2024
In this engaging fireside chat, experts from Bachem discuss the rapid growth and increasing demand in the peptides market, particularly driven by GLP-1 analogs for treating diabetes, obesity, and other metabolic diseases. The conversation highlights the challenges of...